In conclusion, to the contrary of the past cases, the use of PD-1 inhibitors results in tumor thrombus regression and the increased patient survival according to this clinically challenging cohort of advanced HCC patients. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.